A phase 3 clinical trial of duloxetine in patients with chronic low back pai
Phase 3
- Conditions
- Chronic low back pain
- Registration Number
- JPRN-jRCT2080222083
- Lead Sponsor
- SHIONOGI & CO., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Participants with chronic low back pain present on 6 months or longer.
And et al.
Exclusion Criteria
Participants with past history of multiple episodes of drug allergy.
Participants previously treated with duloxetine.
And et al.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change from baseline in Brief Pain Inventory (BPI)-average pain score
- Secondary Outcome Measures
Name Time Method